DNA synthesis Biomemory Bets on Petroleum-Free, Enzymatically Synthesized DNA for Data Storage Premium The Paris-based startup claims it has found a way to produce DNA nucleotides using synthetic biology without ingredients derived from fossil fuels. French DNA Data Storage Startup Biomemory Raises €5M in Seed Funding The DNA synthesis and data storage company will use the funds to further optimize and reduce the cost of its technologies. Catalog, Seagate Partner to Advance DNA-Based Data Storage, Computing Premium Early work will focus on making Catalog's chemistries work in smaller volumes with Seagate's lab-on-a-chip technology, with a goal of femtoliter droplets. Codexis, Molecular Assemblies Ink Commercial License and Enzyme Supply Agreement The agreement grants Molecular Assemblies an exclusive license to Codexis' terminal deoxynucleotidyl transferase enzyme developed for enzymatic DNA synthesis. Synbio Company Replay Launches With $55M in Seed Funding The San Diego and London-based startup aims to tackle gene therapy payload capacity and off-the-shelf cell therapies using its genome medicine technologies. May 24, 2022 Startup Incubator IndieBio, GP-Write Launch Initiative to Fund Genome Engineering Firms Apr 20, 2022 Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service Premium Apr 12, 2022 DNA Script Launches Early-Access Program for Enzymatic DNA Synthesis Platform Apr 11, 2022 Ansa Biotechnologies Closes $68M Series A Financing Mar 28, 2022 Molecular Assemblies to Launch Enzymatic DNA Synthesis as a Service Premium Mar 23, 2022 Codex DNA Q4 Revenues Grow 63 Percent Mar 15, 2022 Molecular Assemblies Raises $25.8M in Series B Financing Mar 14, 2022 Evonetix Developing Thermally Controlled Enzymatic DNA Synthesis Premium Feb 14, 2022 Codex DNA Bets on Enzymatic Building Block Method for Gene Synthesis Premium Jan 20, 2022 Twist Bioscience Sees Demand for New Enzymatic DNA Synthesis Method; Stays Mum on Timeline, Details Premium Nov 9, 2021 DNA Script on Track for Release of Enzymatic DNA Synthesis Platform in 2022 Premium Oct 20, 2021 Biotage Acquires Oligo Maker ATDBio for £45M in Cash, Stock Jul 20, 2021 DNA Manufacturer OriCiro Genomics Raises ¥800M in Series B Round May 6, 2021 Twist Bioscience Q2 Revenues Grow 62 Percent Apr 15, 2021 Molecular Assemblies Extends Series A Financing Round by $11.8M Apr 12, 2021 Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings Mar 18, 2021 DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand' Premium Feb 23, 2021 DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick Feb 5, 2021 Twist Bioscience Reveals MRD Testing Applications, Regeneron Genotyping Project Premium Feb 4, 2021 Twist Bioscience Fiscal Q1 Revenues Grow 64 Percent; JP Morgan Downgrades to Underweight Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.